Premium
Infliximab and adalimumab, unlike ustekinumab, increase serum KL ‐6 levels in Japanese patients with psoriasis
Author(s) -
Yanaba Koichi,
Umezawa Yoshinori,
Sakakihara Reiko,
Chiba Miki,
Ito Toshihiro,
Kikuchi Sota,
Fukuchi Osamu,
Asahina Akihiko,
Saeki Hidehisa,
Nakagawa Hidemi
Publication year - 2015
Publication title -
the journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.9
H-Index - 65
eISSN - 1346-8138
pISSN - 0385-2407
DOI - 10.1111/1346-8138.12918
Subject(s) - medicine , dermatology , adalimumab , ustekinumab , psoriasis , infliximab , family medicine , disease